Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Marc Furrer

13PUBLICATIONS
47CO-AUTHORS
Predictive and prognostic markersCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Respiratory diseasesAutonomic nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

Sort by Publication Date:
|Mar 13, 2026
Risk stratification and conditional recurrence after radical cystectomy: toward adaptive follow-up.

Roberto Contieri, Alberto Martini, Marc Furrer

|Jul 09, 2025
Impact of timing of computed tomography staging and patient factors on the detection of 'true' cN+ bladder cancer.

Markus von Deimling, Marc Furrer, Alberto Bianchi

|Mar 12, 2024
The optimal number of induction chemotherapy cycles in clinically lymph node-positive bladder cancer.

Markus von Deimling, Laura S Mertens, Marc Furrer

|Oct 31, 2023
Impact of the extent of lymph node dissection on survival outcomes in clinically lymph node-positive bladder cancer.

Markus von Deimling, Marc Furrer, Laura S Mertens

|Sep 16, 2023
Detailed reporting of clinical and pathological parameters, and comprehensive depiction of complication-intervention events and grading is required to ensure comparability of survival and morbidity outcomes.

Marc A Furrer, Christopher Soliman, Patrick Y Wuethrich

|Aug 07, 2023
Oncological outcomes after attempted nerve-sparing radical prostatectomy (NSRP) in patients with high-risk prostate cancer are comparable to standard non-NSRP: a longitudinal long-term propensity-matched single-centre study.

Marc A Furrer, Niranjan Sathianathen, Brigitta Gahl

Pageof 3

Frequent Collaborators

5 joint publications

Bernhard Kiss

4 joint publications

Patrick Y Wuethrich

4 joint publications

Francesco Del Giudice

4 joint publications

Renate Pichler

4 joint publications

Andrea Mari

3 joint publications

Yair Lotan

3 joint publications

Roger Li

3 joint publications

Karl H Tully

3 joint publications

Marco Moschini

3 joint publications

Laura S Mertens

Frequent Collaborators

5 joint publications

Bernhard Kiss

4 joint publications

Patrick Y Wuethrich

4 joint publications

Francesco Del Giudice

4 joint publications

Renate Pichler

Top Related Videos

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on : Sep 27, 2024

986
Magnetic Resonance Imaging Assessment of Carcinogen-induced Murine Bladder Tumors
05:19

Magnetic Resonance Imaging Assessment of Carcinogen-induced Murine Bladder Tumors

Published on : Mar 29, 2019

10.4K
Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice:  A Model for Immunotherapy Development
11:02

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on : Oct 30, 2013

21.3K
See more related videos

Top Related Videos

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on : Sep 27, 2024

986
Magnetic Resonance Imaging Assessment of Carcinogen-induced Murine Bladder Tumors
05:19

Magnetic Resonance Imaging Assessment of Carcinogen-induced Murine Bladder Tumors

Published on : Mar 29, 2019

10.4K
Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice:  A Model for Immunotherapy Development
11:02

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on : Oct 30, 2013

21.3K
See more related videos